Shed Expands GLP-1 Weight-Loss Offerings with Wegovy(R) Pills via NovoCare

Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of its GLP-1 weight-loss programs with the introduction of Wegovy(R) pills via ...

OWP Pharmaceuticals Announces Commercial Product Availability of SUBVENITE® (lamotrigine) Oral Suspension in U.S. Market

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
The Barre-Montpelier Times Argus

ESTEVE to Acquire TerSera Therapeutics’ Infusion Specialty Therapies Business Unit, Expanding U.S. Presence

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

What's next for The Standard Germantown? The latest on TIF plan

A public hearing will be held Jan. 20 on The Standard Germantown development, which is the first to request a TIF in ...
Le Lézard

Shed Expands GLP-1 Weight-Loss Offerings with Wegovy® Pills via NovoCare

Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of its GLP-1 weight-loss programs with the introduction of Wegovy® pills via ...
Le Lézard

Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS

Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...
CNBC

The new $6,000 senior tax deduction: who qualifies and how to claim it

The standard deduction has been super-sized for seniors. Thanks to provisions in the One Big Beautiful Bill Act, taxpayers 65 and older can claim an additional $6,000 without itemizing their ...